We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$654M
AUM Growth
+$67.6M
Cap. Flow
+$16.5M
Cap. Flow %
2.53%
Top 10 Hldgs %
16.54%
Holding
278
New
46
Increased
28
Reduced
95
Closed
45

Top Buys

Rank Stock Value
1
CXM icon
Sprinklr
CXM
+$13.2M
2
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$8.97M
3
INSP icon
Inspire Medical Systems
INSP
+$8.27M
4
APPN icon
Appian
APPN
+$8.26M
5
BILL icon
BILL Holdings
BILL
+$8.14M

Top Sells

Rank Stock Value
1
ESTC icon
Elastic
ESTC
+$9.05M
2
CRWD icon
CrowdStrike
CRWD
+$8.85M
3
TEAM icon
Atlassian
TEAM
+$8.82M
4
PLTR icon
Palantir
PLTR
+$8.32M
5
GTLB icon
GitLab
GTLB
+$8.05M

Sector Composition

Rank Sector Weight
1 Technology 34.21%
2 Industrials 13.22%
3 Healthcare 12.51%
4 Energy 6.85%
5 Consumer Discretionary 5.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSCI icon
126
MSCI
MSCI
$40B
$605K 0.09%
1,069
– –
RF icon
127
Regions Financial
RF
$26.3B
$592K 0.09%
30,525
-690
-2% -$11.4K
ICE icon
128
Intercontinental Exchange
ICE
$82.4B
$591K 0.09%
+5,978
New +$678K
PG icon
129
Procter & Gamble
PG
$343B
$589K 0.09%
4,018
+87
+2% +$12.9K
KO icon
130
Coca-Cola
KO
$354B
$556K 0.09%
9,430
+160
+2% +$9.09K
BRK.A icon
131
Berkshire Hathaway Class A
BRK.A
$1.07T
$543K 0.08%
100
– –
CVS icon
132
CVS Health
CVS
$137B
$540K 0.08%
6,833
– –
V icon
133
Visa
V
$677B
$524K 0.08%
+4,532
New +$1.12M
SRE icon
134
Sempra
SRE
$60.8B
$475K 0.07%
+6,351
New +$454K
BAC icon
135
Bank of America
BAC
$435B
$471K 0.07%
14,000
– –
META icon
136
Meta Platforms (Facebook)
META
$1.51T
$469K 0.07%
1,326
-75
-5% -$24.4K
NEE icon
137
NextEra Energy
NEE
$187B
$462K 0.07%
+6,376
New +$363K
BNY
138
Bank of New York Mellon
BNY
$108B
$462K 0.07%
+8,872
New +$409K
HSY icon
139
Hershey
HSY
$35.4B
$436K 0.07%
2,339
+181
+8% +$34.3K
DUK icon
140
Duke Energy
DUK
$102B
$428K 0.07%
+4,831
New +$439K
BX icon
141
Blackstone
BX
$104B
$424K 0.06%
3,242
– –
PEP icon
142
PepsiCo
PEP
$186B
$416K 0.06%
2,452
-35
-1% -$5.8K
IJH icon
143
iShares Core S&P Mid-Cap ETF
IJH
$123B
$416K 0.06%
7,495
-200
-3% -$10.1K
MCD icon
144
McDonald's
MCD
$188B
$410K 0.06%
1,383
-13
-0.9% -$3.54K
MRK icon
145
Merck
MRK
$324B
$401K 0.06%
3,678
+219
+6% +$22.7K
XNTK icon
146
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
$400K 0.06%
2,079
– –
NFLX icon
147
Netflix
NFLX
$292B
$373K 0.06%
+7,670
New +$335K
GSK icon
148
GSK
GSK
$103B
$355K 0.05%
+9,589
New +$344K
ACN icon
149
Accenture
ACN
$89.9B
$330K 0.05%
939
-80
-8% -$25.8K
VEA icon
150
Vanguard FTSE Developed Markets ETF
VEA
$226B
$329K 0.05%
6,875
+43
+0.6% +$1.93K
4 5
6
7 8

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q4 2023 Portfolio in Review

As of Q4 2023, Stanley-Laman Group held 278 positions worth $654M, up 12% from $586M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Stanley-Laman Group's Q4 2023 filing shows 46 new, 28 increased, 95 reduced and 45 closed positions. Its largest new stake was Shockwave Medical, Inc. Common Stock: 47,471 shares worth $9.05M. The largest sale was Elastic, an estimated $9.05M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q4 2023 buy was Shockwave Medical, Inc. Common Stock: 47,471 shares worth $9.05M.
  • Stanley-Laman Group added most to Sprinklr in Q4 2023, an estimated $13.2M increase.
  • Stanley-Laman Group's biggest Q4 2023 reduction was Eli Lilly, cutting an estimated $909K.
  • Stanley-Laman Group fully exited Elastic in Q4 2023, selling an estimated $9.05M.
  • Stanley-Laman Group's ten largest holdings make up 17% of its $654M portfolio in Q4 2023.
  • Stanley-Laman Group opened 46 new positions and closed 45 in Q4 2023.
  • Stanley-Laman Group's portfolio value rose 12% quarter-over-quarter to $654M.

Based on Stanley-Laman Group's 13F filing for Q4 2023, filed 2 Feb 2024.